Travelzoo - TZOO Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Travelzoo in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TZOO shares.
View TZOO analyst ratings or view top-rated stocks.

2 brokers have issued 12-month target prices for Travelzoo's shares. Their TZOO share price forecasts range from $10.00 to $16.00. On average, they expect the company's share price to reach $13.00 in the next year. This suggests a possible upside of 115.2% from the stock's current price.
View analysts price targets for TZOO or view top-rated stocks among Wall Street analysts.

Travelzoo's stock was trading at $4.45 at the start of the year. Since then, TZOO shares have increased by 35.7% and is now trading at $6.04.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our TZOO earnings forecast.

Travelzoo (NASDAQ:TZOO) issued its earnings results on Thursday, October, 28th. The information services provider reported $0.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.01. The information services provider had revenue of $15.69 million for the quarter, compared to the consensus estimate of $20.26 million. Travelzoo had a trailing twelve-month return on equity of 3,473.88% and a net margin of 9.40%. During the same period last year, the business earned ($0.10) earnings per share.

59 employees have rated Travelzoo Chief Executive Officer Holger Bartel on Glassdoor.com. Holger Bartel has an approval rating of 44% among the company's employees. This puts Holger Bartel in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Travelzoo investors own include Onconova Therapeutics (ONTX), Allena Pharmaceuticals (ALNA), T2 Biosystems (TTOO), Arbutus Biopharma (ABUS), Amarin (AMRN), Ford Motor (F), Las Vegas Sands (LVS), OPKO Health (OPK), Sorrento Therapeutics (SRNE) and AbbVie (ABBV).

Travelzoo trades on the NASDAQ under the ticker symbol "TZOO."

Shares of TZOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TZOO stock can currently be purchased for approximately $6.04.

Travelzoo (NASDAQ:TZOO) has a market capitalization of $94.83 million and generates $70.60 million in revenue each year. The information services provider earns $6.63 million in net income (profit) each year or $0.53 on an earnings per share basis.

The company employs 214 workers across the globe.

Travelzoo's mailing address is 590 Madison Avenue 35th Floor, New York NY, 10022. The official website for the company is www.travelzoo.com. The information services provider can be reached via phone at (212) 484-4900, via email at ir@travelzoo.com, or via fax at 212-521-4230.